Pharmacokinetics and Clinical Effects of Escalating Doses of Clonidine in ICU Patients
Status:
Completed
Trial end date:
2018-04-05
Target enrollment:
Participant gender:
Summary
This study is developed for assessing the pharmacodynamic and pharmacokinetic properties of
intravenous (IV) clonidine in critically ill patients on the ICU, and to estimate the optimal
dosing strategy for IV clonidine.